OSUR : Analysis & Opinions

  1. Non-Remedial Stocks Poised to Beat Zika

    September 16, 2016
    While Zika virus medicines continue in lengthy development cycles, non-remedial stocks offer potential benefits.
  2. How Merck and Daktari Are Working together to Create the HCV ...

    March 12, 2016
    Find out why Merck invested in privately owned Daktari Diagnostics, a company working on a Hepatitis C diagnostics test. ...